AMSBIO has added new experimental cell lines to its CAR T cell research range.

Pivotal Phase III study will further evaluate the efficacy of candidate NB-01 on pain associated with diabetic neuropathy.

AiCure to provide AI-driven behavioral insights and improve patient compliance for NeuroBo's Phase III Diabetic Neuropathic Pain Trial.

Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.

Arbor have recently expanded into synthetic biology with a cell-free expression system using linear DNA as template for rapid protein expression.

The assay will be used to discover and develop new treatments for autoimmune diseases and cancer by strategically targeting the cGAS-STING pathway.

Published in the peer-reviewed journal mAbs, the paper introduces complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

Building upon over 50 years of freeze-drying experience, the LyoS 2.0 control system delivers unmatched process control for all stages of the cycle, from freezing to primary and secondary drying.

New 10-colour system with Kaluza C software streamlines workflow and QC reporting for flow cytometric leukemia & lymphoma* analysis.

Integrated with the latest version of Lonza’s proprietary dynamic control WinKQCL™ 6.0 Software platform, the new system has been designed to meet the rapidly changing needs of QC testing laboratories for fully automated processing of simple to complex sample matrices.